PD Dr. Gabriele Weitz-Schmidt, AlloCyte Pharmaceuticals AG, Basel

Development of a new generation of integrin targeting drugs

Start Date 17.05.2017 - 17:00
Event End 17.05.2017 - 18:00
Location Universität Basel, Pharmazentrum

Development of a new generation of integrin targeting drugs